Status | Study |
Completed |
Study Name: Therapeutic Use of Tadekinig Alfa in Adult-onset Still's Disease Condition: Still's Disease, Adult-Onset Date: 2015-02-23 Interventions: Biological: Tadekinig alfa (recombinant human IL-18 binding protein) Patients received the study treatme |
Recruiting |
Study Name: Canakinumab for Treatment of Adult Onset Still's Disease Condition: Adult-Onset Still´s Disease Date: 2014-07-29 Interventions: Drug: Canakinumab Canakinumab |
Completed |
Study Name: Treatment of Refractory Adult-onset Still's Disease With Anakinra: a Randomized Study Condition: Adult-Onset Still's Disease Date: 2009-12-15 Interventions: Drug: anakinra 100 mg subcutan |
Completed |
Study Name: Efficacy and Safety of Tocilizumab in Adult's Still Disease Condition: Adult's Still Disease Date: 2009-10-26 Interventions: Drug: Tocilizumab Tocilizumab, IV, 8 mg/kg, every 2 weeks |
Completed |
Study Name: Interleukin-1 Trap to Treat Autoinflammatory Diseases Condition: Inflammation Familial Mediterranean Fever Still's Disease, Date: 2004-10-28 Interventions: Drug: IL-1 Trap |